Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply

Aliment Pharmacol Ther. 2021 Jul;54(2):216. doi: 10.1111/apt.16462.

Authors

Jung Gil Park^{1

2}, Jinho Jung¹, Rohit Loomba^{1

3}

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.
² Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, South Korea.
³ Department of Family Medicine and Public Health, University of California at San Diego, La Jolla, CA, USA.

PMID: 34170539
DOI: 10.1111/apt.16462

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Coronary Artery Disease* / diagnosis
Humans
Liver Cirrhosis / complications
Liver Cirrhosis / diagnosis
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / diagnosis

Grants and funding